Interferon beta-1a Completed Phase 2 Trials for Alzheimer's Disease (AD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01075763A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease